Hyperliquid Strategies

Hyperliquid Strategies Debt/EBITDA

Total Debt to EBITDA Ratio of Hyperliquid Strategies (PURR) as of Oct 30, 2026.

Debt/EBITDA

-

Last updated:

Total Debt to EBITDA Ratio of Hyperliquid Strategies is 2026 - . Total Debt to EBITDA Ratio of Hyperliquid Strategies was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hyperliquid Strategies Stock analysis

What does Hyperliquid Strategies do? Hyperliquid Strategies Inc generates revenue through its subsidiary Sonnet BioTherapeutics Holdings, Inc., which develops oncology-focused biologic drugs. The company accumulates HYPE, the native token of Hyperliquid, a blockchain platform designed for financial applications. Sonnet BioTherapeutics operates in the biotechnology sector with a proprietary drug innovation platform. The firm targets biotech investors and pharmaceutical partners seeking advanced oncology treatments. Hyperliquid Strategies Inc's business model centers on digital asset treasury management, leveraging HYPE token holdings. The company's primary products include biologic drugs developed by Sonnet BioTherapeutics and HYPE token assets. Biotechnology investors and pharmaceutical companies represent key customer segments purchasing these products. The firm focuses on high-performance blockchain infrastructure for financial services through its subsidiary's operations. Hyperliquid Strategies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hyperliquid Strategies stock

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Hyperliquid Strategies since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Hyperliquid Strategies with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Hyperliquid Strategies

All Key Metrics — Hyperliquid Strategies